Allogene Therapeutics Inc.
ALLO | NASDAQ
$1.71
+$0.02 (+1.18%)
Sep 22, 2026, 1:32 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 51.69M | 75.22M | 83.16M | 61.9M | 173.31M | 183.35M |
Short-Term Investments | 198.52M | 217.26M | 365.54M | 455.42M | 283.99M | 644.56M |
Long-Term Investments | 8.04M | 80.67M | 3.65M | 76.47M | 382.38M | 207.95M |
Other Long-Term Assets | 37.39M | 33.39M | 16.9M | 19.86M | 16.11M | 14.62M |
Receivables | 1.5M | 1.9M | 1.7M | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 6.04M | 9.01M | n/a | 11.5M | n/a | n/a |
Total Current Assets | 257.75M | 303.39M | 459.12M | 528.82M | 471.32M | 845.13M |
Property-Plant & Equipment | 112.73M | 131.26M | 163.18M | 196.43M | 181.02M | 160.14M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 158.16M | 245.32M | 183.72M | 292.76M | 579.51M | 382.7M |
Total Assets | 415.91M | 548.71M | 642.84M | 821.58M | 1.05B | 1.23B |
Account Payables | 4.27M | 5.39M | 5.9M | 13.89M | 10.26M | 10.39M |
Deferred Revenue | n/a | n/a | 86K | 95K | 156K | 38.99M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 10.24M | 12.15M | 11.66M | 17.94M | 16.13M | 12.97M |
Total Current Liabilities | 32.51M | 35.52M | 37.08M | 53.73M | 47.91M | 94.32M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 15.8M | 7.76M | 5.18M | 5.85M | 7.79M | 3.08M |
Total Long-Term Liabilities | 90.85M | 91.01M | 93.53M | 100.97M | 77.72M | 53.89M |
Total Liabilities | 123.36M | 126.53M | 130.6M | 154.7M | 125.63M | 148.21M |
Total Debt | 83.25M | 90.76M | 95.12M | 101.12M | 73.13M | 53.78M |
Book Value | 292.54M | 422.18M | 512.23M | 666.88M | 925.2M | 1.08B |
Book Value Per Share | 1.33 | 2.17 | 3.26 | 4.66 | 6.81 | 8.97 |
Common Stock | 229K | 212K | 169K | 144K | 142K | 140K |
Retained Earnings | -2.01B | -1.82B | -1.56B | -1.23B | -894.55M | -646.34M |
Comprehensive Income | 269K | -89K | -955K | -9.93M | -2.57M | 268K |
Shareholders Equity | 292.54M | 422.18M | 512.23M | 666.88M | 925.2M | 1.08B |
Total Investments | 206.57M | 297.93M | 369.19M | 531.88M | 666.37M | 852.51M |
Add to Watchlist
Select watchlists to add or remove ALLO